Director Share Purchase

RNS Number : 8280G

Alliance Pharma PLC

28 October 2008

 



For Immediate Release

28 October 2008

ALLIANCE PHARMA PLC

('the Company')

Director Share Purchase

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 27 October 2008 that Michael Gatenby, the Company's Chairman, purchased 220,000 ordinary shares of 1p each in the Company on 27 October 2008 at a price of 4.0p per share. Mr Gatenby's resultant shareholding is 350,000 ordinary shares, equivalent to 0.22 per cent. of the Company's issued share capital.

For further information: 

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications	+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney

 

END

 

 

RDSFKFKQKBDDOKB